首页> 美国卫生研究院文献>Epigenetics Chromatin >Rapid analysis of heterogeneously methylated DNA using digital methylation-sensitive high resolution melting: application to the CDKN2B (p15) gene
【2h】

Rapid analysis of heterogeneously methylated DNA using digital methylation-sensitive high resolution melting: application to the CDKN2B (p15) gene

机译:使用数字甲基化敏感的高分辨率熔解技术快速分析异质甲基化的DNA:应用于CDKN2B(p15)基因

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

BackgroundMethylation-sensitive high resolution melting (MS-HRM) methodology is able to recognise heterogeneously methylated sequences by their characteristic melting profiles. To further analyse heterogeneously methylated sequences, we adopted a digital approach to MS-HRM (dMS-HRM) that involves the amplification of single templates after limiting dilution to quantify and to determine the degree of methylation. We used this approach to study methylation of the CDKN2B (p15) cell cycle progression inhibitor gene which is inactivated by DNA methylation in haematological malignancies of the myeloid lineage. Its promoter region usually shows heterogeneous methylation and is only rarely fully methylated. The methylation status of CDKN2B can be used as a biomarker of response to treatment. Therefore the accurate characterisation of its methylation is desirable.
机译:背景技术甲基化敏感的高分辨率熔解(MS-HRM)方法能够通过其特有的熔解曲线识别异质甲基化序列。为了进一步分析异质甲基化序列,我们对MS-HRM采用了一种数字方法(dMS-HRM),该方法涉及在有限稀释后对单个模板进行扩增,以定量和确定甲基化程度。我们使用这种方法来研究CDKN2B(p15)细胞周期进程抑制剂基因的甲基化,该基因在骨髓谱系的血液系统恶性肿瘤中被DNA甲基化所灭活。其启动子区域通常显示异质甲基化,很少被完全甲基化。 CDKN2B的甲基化状态可以用作对治疗反应的生物标记。因此,需要对其甲基化的准确表征。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号